AU658187B2 - Human bone derived insulin like growth factor binding protein - Google Patents

Human bone derived insulin like growth factor binding protein Download PDF

Info

Publication number
AU658187B2
AU658187B2 AU17844/92A AU1784492A AU658187B2 AU 658187 B2 AU658187 B2 AU 658187B2 AU 17844/92 A AU17844/92 A AU 17844/92A AU 1784492 A AU1784492 A AU 1784492A AU 658187 B2 AU658187 B2 AU 658187B2
Authority
AU
Australia
Prior art keywords
igfbp
hbd
igf
binds
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU17844/92A
Other languages
English (en)
Other versions
AU1784492A (en
Inventor
David J. Baylink
Subburaman Mohan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU1784492A publication Critical patent/AU1784492A/en
Application granted granted Critical
Publication of AU658187B2 publication Critical patent/AU658187B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU17844/92A 1991-04-19 1992-04-15 Human bone derived insulin like growth factor binding protein Ceased AU658187B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68835391A 1991-04-19 1991-04-19
US688353 1991-04-19
PCT/US1992/003122 WO1992018154A1 (en) 1991-04-19 1992-04-15 Human bone derived insulin like growth factor binding protein

Publications (2)

Publication Number Publication Date
AU1784492A AU1784492A (en) 1992-11-17
AU658187B2 true AU658187B2 (en) 1995-04-06

Family

ID=24764088

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17844/92A Ceased AU658187B2 (en) 1991-04-19 1992-04-15 Human bone derived insulin like growth factor binding protein

Country Status (11)

Country Link
EP (1) EP0580752A4 (cs)
JP (1) JP2527896B2 (cs)
KR (1) KR0129864B1 (cs)
AU (1) AU658187B2 (cs)
CA (1) CA2107475A1 (cs)
CZ (1) CZ283601B6 (cs)
FI (1) FI934588A0 (cs)
HU (1) HUT70297A (cs)
NO (1) NO933742L (cs)
RU (1) RU2114120C1 (cs)
WO (1) WO1992018154A1 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE247164T1 (de) 1991-01-08 2003-08-15 Chiron Corp Insulinartigen wachstumsfaktor bindendes protein
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
CA2195474A1 (en) * 1994-07-20 1996-02-01 Cedo Martin Bagi Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
EP0871730B1 (en) 1995-10-11 2004-08-18 Chiron Corporation Combination pdgf, kgf, igf and igfbp for wound healing
ES2344592T3 (es) 2001-01-05 2010-09-01 Pfizer Inc. Anticuerpos frente al receptor del factor de crecimiento similar a la insulina i.
RU2342159C2 (ru) * 2004-07-16 2008-12-27 Пфайзер Продактс Инк. Комбинированная терапия негематологических злокачественных опухолей с использованием анти-igf-1r-антитела
CN108699127A (zh) 2015-12-31 2018-10-23 西门子医疗保健诊断公司 非重组人胰岛素-样生长因子结合蛋白浓缩物
US10212614B2 (en) * 2015-12-31 2019-02-19 Facebook, Inc. Igniting network nodes in a multi-hop wireless network

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028434A1 (en) * 1979-10-30 1981-05-13 Jacques Adriaan De Wijn Cart, undercarriage with foldable wheels
US4642120A (en) * 1983-03-23 1987-02-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Repair of cartilage and bones

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0289314B1 (en) * 1987-04-28 1994-10-12 Roche Diagnostics GmbH Use of IGF-II in the treatment of bone disorders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0028434A1 (en) * 1979-10-30 1981-05-13 Jacques Adriaan De Wijn Cart, undercarriage with foldable wheels
US4642120A (en) * 1983-03-23 1987-02-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Repair of cartilage and bones

Also Published As

Publication number Publication date
KR0129864B1 (en) 1998-04-09
EP0580752A1 (en) 1994-02-02
FI934588A7 (fi) 1993-10-18
JPH06501270A (ja) 1994-02-10
FI934588L (fi) 1993-10-18
JP2527896B2 (ja) 1996-08-28
NO933742L (no) 1993-10-18
CA2107475A1 (en) 1992-10-20
AU1784492A (en) 1992-11-17
HUT70297A (en) 1995-09-28
FI934588A0 (fi) 1993-10-18
CZ219093A3 (en) 1994-12-15
RU2114120C1 (ru) 1998-06-27
CZ283601B6 (cs) 1998-05-13
WO1992018154A1 (en) 1992-10-29
HU9302942D0 (en) 1994-01-28
EP0580752A4 (en) 1994-08-24

Similar Documents

Publication Publication Date Title
US5736511A (en) Methods for treatment using acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US5747452A (en) Method of modulating tumor cell migration using fibronectin type III peptides
EP0775742A2 (en) Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix
JP2648951B2 (ja) 人体のソマトメジン担体蛋白質サブユニットとこれらの製法
JP3178714B2 (ja) インスリン様成長因子（ｉｇｆ）結合蛋白複合体の酸不安定サブユニット（ａｌｓ）
EP0546110B1 (en) New insulin-like growth factor binding protein igfbp-5
AU658187B2 (en) Human bone derived insulin like growth factor binding protein
EP0546074B1 (en) Genetic material encoding igfbp-5
US5453489A (en) Polypeptide fragments of fibronectin which can modulate extracellular matrix assembly
Gysen et al. Radioimmunoassay of proteoglycans
IE913033A1 (en) Genetic material encoding new insulin-like growth factor¹binding protein (igfbp-4)
US5919902A (en) Leptin bound to inter-alphatrypsin inhibitor and uses thereof
JPH11506337A (ja) 骨刺激因子
IE913032A1 (en) New insulin-like growth factor binding protein (igfbp-4)
WO1994025057A1 (en) Kgf receptor-derived antagonists of kgf binding
WO1999049894A1 (en) Antagonists to growth arrest specific gene 6 to treat insulin-resistant disorders
US5693754A (en) Inhibitory binding protein for insulin-like growth factors
AU638935B2 (en) Acid-labile subunit (als) of insulin-like-growth factor (igf)binding protein complex
US6329500B1 (en) Transforming growth factor-β binding site
US6465423B1 (en) Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
CA2191321A1 (en) Gene coding for modified bone morphogenic protein receptor
US20030027753A1 (en) Bone stimulating factor
MXPA97009618A (en) Hue stimulating factors

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired